Graphene Oxide: A Potential Drug Carrier for Cancer Therapy—Review

Authors

  • Miyanda Petty M. Department of Pharmaceutics, CT Institute of Pharmaceutical Sciences, Shahpur, Jalandhar, Punjab, India
  • Surya Gautam

DOI:

https://doi.org/10.37591/(rrjops).v8i3.6

Abstract

Graphene oxide (GO) is a single or few layer’s sheet derived from graphite using strong oxidizing agents. Graphene oxide possesses outstanding aqueous processability, amphiphilicity, functionalizability, surface enhanced area and fluorescence ability. Hydrophilicity is an important property for mixing the material with ceramic or polymer matrixes while trying to improve their electrical and mechanical properties. Acquiring a promising application in the biomedical area, graphene molecules undergo complex interactions with the biological system, resulting in toxicity of the molecule. However, various approaches to overcome these problems have been established involving graphene modification, leading to the emerging role for graphene oxide, highly-tailored multifunctional targeted delivery vehicles of therapeutic agents to cancer cells or tissues due to its enhanced tissue penetration and cellular uptake both in vitro and in vivo. This review covers graphene oxide properties, functionalization, cytotoxicity and recent potential research studies on GO application in cancer therapy for the past 5 years (2013–2017).

Keywords: Graphene oxide, functionalization, targeted delivery, cancer therapy

Cite this Article Miyanda Petty M, Surya Gautam. Graphene Oxide: A Potential Drug Carrier for Cancer Therapy: Review Article. Research & Reviews: A Journal of Pharmaceutical Science. 2017; 8(3): 21–31p. 

Downloads

Published

2017-12-16

Issue

Vol. 8 No. 3 (2017)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.